WHEN Stephane Castel first met with a group of Maori people and other Pacific Islanders in New Zealand to discuss his biotech company’s plans for genetic research, the reception was cautious.
Community members feared a repeat of past exploitations where researchers profited from their genetic material without regard for their welfare.
